SINGAPORE, Dec. 11, 2018 /PRNewswire/ -- Brain health-focused pharmaceutical company Cerecin, today announced that it is a sponsor for the Alzheimer's Disease Therapeutics: Alternatives to Amyloid Symposium to be held in New York, New York, USA. Dr. Samuel Henderson, Cerecin's Chief... |